Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Neurodegeneration cannabidiol:

Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive Cannabinoid. Kozela E et al. Int J Mol Sci. (2017)

The therapeutic potential of the phytocannabinoid cannabidiol for Alzheimer's disease. Karl T et al. Behav Pharmacol. (2017)

Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia. Mori MA et al. Prog Neuropsychopharmacol Biol Psychiatry. (2017)

Search results

Items: 1 to 20 of 37

1.

Neuronal preservation and reactive gliosis attenuation following neonatal sciatic nerve axotomy by a fluorinated cannabidiol derivative.

Perez M, Cartarozzi LP, Chiarotto GB, Oliveira SA, Guimarães FS, Oliveira ALR.

Neuropharmacology. 2018 Sep 15;140:201-208. doi: 10.1016/j.neuropharm.2018.08.009. Epub 2018 Aug 7.

PMID:
30096328
2.

Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders?

Peres FF, Lima AC, Hallak JEC, Crippa JA, Silva RH, Abílio VC.

Front Pharmacol. 2018 May 11;9:482. doi: 10.3389/fphar.2018.00482. eCollection 2018. Review.

3.

Paraneoplastic cerebellar degeneration: Yo antibody alters mitochondrial calcium buffering capacity.

Panja D, Vedeler CA, Schubert M.

Neuropathol Appl Neurobiol. 2018 Apr 21. doi: 10.1111/nan.12492. [Epub ahead of print]

PMID:
29679372
4.

Cannabidiol Reverses Deficits in Hippocampal LTP in a Model of Alzheimer's Disease.

Hughes B, Herron CE.

Neurochem Res. 2018 Mar 24. doi: 10.1007/s11064-018-2513-z. [Epub ahead of print]

PMID:
29574668
5.

Novel insights into mitochondrial molecular targets of iron-induced neurodegeneration: Reversal by cannabidiol.

da Silva VK, de Freitas BS, Dornelles VC, Kist LW, Bogo MR, Silva MC, Streck EL, Hallak JE, Zuardi AW, Crippa JAS, Schröder N.

Brain Res Bull. 2018 May;139:1-8. doi: 10.1016/j.brainresbull.2018.01.014. Epub 2018 Jan 31.

PMID:
29374603
6.

Prospects of Cannabidiol for Easing Status Epilepticus-Induced Epileptogenesis and Related Comorbidities.

Upadhya D, Castro OW, Upadhya R, Shetty AK.

Mol Neurobiol. 2018 Aug;55(8):6956-6964. doi: 10.1007/s12035-018-0898-y. Epub 2018 Jan 25. Review.

PMID:
29372545
7.

Attenuation of early phase inflammation by cannabidiol prevents pain and nerve damage in rat osteoarthritis.

Philpott HT, OʼBrien M, McDougall JJ.

Pain. 2017 Dec;158(12):2442-2451. doi: 10.1097/j.pain.0000000000001052.

8.

Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive Cannabinoid.

Kozela E, Juknat A, Vogel Z.

Int J Mol Sci. 2017 Jul 31;18(8). pii: E1669. doi: 10.3390/ijms18081669. Review.

9.

Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders.

Campos AC, Fogaça MV, Scarante FF, Joca SRL, Sales AJ, Gomes FV, Sonego AB, Rodrigues NS, Galve-Roperh I, Guimarães FS.

Front Pharmacol. 2017 May 23;8:269. doi: 10.3389/fphar.2017.00269. eCollection 2017. Review.

10.

Protective Effects of Cannabidiol against Seizures and Neuronal Death in a Rat Model of Mesial Temporal Lobe Epilepsy.

Do Val-da Silva RA, Peixoto-Santos JE, Kandratavicius L, De Ross JB, Esteves I, De Martinis BS, Alves MN, Scandiuzzi RC, Hallak JE, Zuardi AW, Crippa JA, Leite JP.

Front Pharmacol. 2017 Mar 17;8:131. doi: 10.3389/fphar.2017.00131. eCollection 2017.

11.

Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia.

Mori MA, Meyer E, Soares LM, Milani H, Guimarães FS, de Oliveira RMW.

Prog Neuropsychopharmacol Biol Psychiatry. 2017 Apr 3;75:94-105. doi: 10.1016/j.pnpbp.2016.11.005. Epub 2016 Nov 23.

PMID:
27889412
12.

A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia.

Osborne AL, Solowij N, Weston-Green K.

Neurosci Biobehav Rev. 2017 Jan;72:310-324. doi: 10.1016/j.neubiorev.2016.11.012. Epub 2016 Nov 22. Review.

PMID:
27884751
13.

The therapeutic potential of the phytocannabinoid cannabidiol for Alzheimer's disease.

Karl T, Garner B, Cheng D.

Behav Pharmacol. 2017 Apr;28(2 and 3-Spec Issue):142-160. doi: 10.1097/FBP.0000000000000247. Review.

PMID:
27471947
14.

Interaction between the protective effects of cannabidiol and palmitoylethanolamide in experimental model of multiple sclerosis in C57BL/6 mice.

Rahimi A, Faizi M, Talebi F, Noorbakhsh F, Kahrizi F, Naderi N.

Neuroscience. 2015 Apr 2;290:279-87. doi: 10.1016/j.neuroscience.2015.01.030. Epub 2015 Jan 28.

PMID:
25637488
15.

Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids.

Pryce G, Riddall DR, Selwood DL, Giovannoni G, Baker D.

J Neuroimmune Pharmacol. 2015 Jun;10(2):281-92. doi: 10.1007/s11481-014-9575-8. Epub 2014 Dec 24. Review.

PMID:
25537576
16.

Type 1 cannabinoid receptor ligands display functional selectivity in a cell culture model of striatal medium spiny projection neurons.

Laprairie RB, Bagher AM, Kelly ME, Dupré DJ, Denovan-Wright EM.

J Biol Chem. 2014 Sep 5;289(36):24845-62. doi: 10.1074/jbc.M114.557025. Epub 2014 Jul 18.

17.

Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 mice.

Cheng D, Low JK, Logge W, Garner B, Karl T.

Psychopharmacology (Berl). 2014 Aug;231(15):3009-17. doi: 10.1007/s00213-014-3478-5. Epub 2014 Mar 1.

PMID:
24577515
18.

Protective effects of cannabidiol against hippocampal cell death and cognitive impairment induced by bilateral common carotid artery occlusion in mice.

Schiavon AP, Soares LM, Bonato JM, Milani H, Guimarães FS, Weffort de Oliveira RM.

Neurotox Res. 2014 Nov;26(4):307-16. doi: 10.1007/s12640-014-9457-0. Epub 2014 Feb 15.

PMID:
24532152
19.

Transdermal delivery of cannabidiol attenuates binge alcohol-induced neurodegeneration in a rodent model of an alcohol use disorder.

Liput DJ, Hammell DC, Stinchcomb AL, Nixon K.

Pharmacol Biochem Behav. 2013 Oct;111:120-7. doi: 10.1016/j.pbb.2013.08.013. Epub 2013 Sep 5. Erratum in: Pharmacol Biochem Behav. 2014 Nov;126:187-8.

20.

Neuroprotection and reduction of glial reaction by cannabidiol treatment after sciatic nerve transection in neonatal rats.

Perez M, Benitez SU, Cartarozzi LP, Del Bel E, Guimarães FS, Oliveira AL.

Eur J Neurosci. 2013 Nov;38(10):3424-34. doi: 10.1111/ejn.12341. Epub 2013 Aug 25.

PMID:
23981015

Supplemental Content

Loading ...
Support Center